Theriva’s oncolytic virus succeeds in pancreatic cancer study, but stock falls
Theriva Biologics' experimental oncolytic virus treatment and chemotherapy helped patients in a mid-stage study stay alive longer than chemotherapy alone. The company said Wednesday that the Phase 2b study included 96 ...
Theriva Biologics' experimental oncolytic virus treatment and chemotherapy helped patients in a mid-stage study stay alive longer than chemotherapy alone.
The company said Wednesday that the Phase 2b study included 96 ...
